FOXM1 and nasopharyngeal carcinoma: The CCK-8 assay indicated that compared with the control group, suppression of USP21 notably inhibited nasopharyngeal carcinoma cell proliferation ability, while overexpression of FOXM1 obviously reversed the cell proliferation ability of nasopharyngeal carcinoma cell lines (Figure 4(c)).